What is the treatment for Group D streptococcal infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Group D Streptococcal Infections

The treatment of choice for Group D streptococcal infections is a combination of penicillin or ampicillin with an aminoglycoside (such as gentamicin) for synergistic bactericidal activity, particularly in serious infections like endocarditis. 1

Treatment Regimens Based on Infection Type

For Endocarditis

  • First-line therapy:
    • Penicillin G or Ampicillin PLUS Gentamicin 1, 2
    • Duration: At least 4-6 weeks for native valve endocarditis; minimum 6 weeks for prosthetic valve endocarditis 1

For Less Severe Infections

  • Oral therapy options:
    • Amoxicillin: 50 mg/kg once daily (maximum 1,000 mg) or 25 mg/kg twice daily (maximum 500 mg per dose) for 10 days 3
    • Penicillin V: For adults, 250 mg 3-4 times daily or 500 mg twice daily for 10 days 3

For Penicillin-Allergic Patients

  • Alternative regimens:
    • Vancomycin: 30 mg/kg/day IV in 2 doses for 4-6 weeks (for serious infections) 1
    • For less severe infections in penicillin-allergic patients:
      • Clindamycin: 7 mg/kg three times daily (maximum 300 mg per dose) for 10 days 3
      • Macrolides (if susceptible): Clarithromycin or Azithromycin 3

Important Considerations

Antimicrobial Resistance

  • Group D streptococci can develop high-level resistance to aminoglycosides (found in approximately 12% of Enterococcus faecalis strains) 4
  • No penicillin resistance has been documented in Group A streptococci, but this doesn't necessarily apply to Group D 1
  • When treating serious infections, susceptibility testing is crucial to guide therapy 2

Monitoring During Treatment

  • For patients receiving gentamicin:
    • Monitor renal function and serum gentamicin concentrations weekly
    • Pre-dose (trough) concentrations should be <1 mg/L
    • Post-dose (peak) serum concentrations should be 10-12 mg/L 1
  • For patients receiving vancomycin:
    • Pre-dose (trough) levels should be 10-15 mg/L
    • Post-dose (peak) levels should be 30-45 mg/L 1

Special Situations

  • For prosthetic valve endocarditis:
    • Longer treatment duration (minimum 6 weeks) compared to native valve endocarditis 1
    • Consider surgical intervention if medical therapy fails 5
  • For neonatal sepsis:
    • Combination therapy with penicillin and aminoglycoside is effective 6
    • Most infants show clinical improvement within 48 hours of appropriate therapy 6

Treatment Algorithm

  1. Assess severity of infection:

    • Life-threatening/invasive (endocarditis, meningitis, sepsis): Use IV combination therapy
    • Non-severe/localized: Consider oral monotherapy
  2. Check for penicillin allergy:

    • No allergy: Use penicillin-based regimens
    • Allergy present: Use alternative regimens (vancomycin, clindamycin)
  3. Obtain cultures and susceptibility testing before or at initiation of therapy to guide treatment 2

  4. Monitor clinical response:

    • If improving: Complete full course of antibiotics
    • If not improving after 48-72 hours: Reassess diagnosis, consider resistance, and adjust therapy accordingly

Common Pitfalls

  • Inadequate duration of therapy: Ensure complete course even if symptoms resolve quickly
  • Failure to use combination therapy for serious infections: The synergistic effect of penicillin plus aminoglycoside is crucial for treating severe Group D streptococcal infections 1, 5
  • Not monitoring for aminoglycoside toxicity: Regular monitoring of renal function and drug levels is essential
  • Misidentification of the organism: Group D streptococci include both enterococci and non-enterococci (like S. bovis), which may have different resistance patterns 4

Remember that medical failure may occur despite appropriate antibiotic therapy, particularly in endocarditis cases, and surgical intervention may be necessary in these situations 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Streptococcal Pharyngitis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Systemic group D streptococcal infection in newborn infants.

American journal of diseases of children (1960), 1979

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.